As filed with the Securities and Exchange Commission on January 12, 2026 Registration No. 333-291410 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Braiin Limited (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) Australia 6770 98-1850021 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 28 ...

Group 1 - Applied Digital plans to spin off its cloud computing business and merge it with EKSO to form a new entity named "ChronoScale Corporation," with Applied Digital retaining approximately 97% ownership post-transaction, expected to complete in the first half of 2026 [2] - The launch of "Loomos AI Display Glasses S1" by Shanjiji, featuring the "Phoenix Architecture 2.0," aims to redefine "active AI glasses" with lightweight design and advanced display technology, focusing on "active AI reminders" [2] - RunningHub and Alibaba's ComfyUI-Copilot have launched the world's first commercial ComfyUI-Agent, marking a significant advancement in AIGC workflow development, transitioning from "tool empowerment" to a new paradigm of "ecological intelligence" [2] - The release of the world's first vertical large language model "Ruixue" in Nanjing signifies a shift in agricultural practices from traditional methods to data modeling and intelligent prediction, supporting sustainable agricultural production [2]

Core Viewpoint - Deveron Corp. has successfully held a special meeting of shareholders where all proposed resolutions were approved, marking significant changes for the company, including a major asset sale and a name change [1][2][3][4][5][6]. Group 1: Approval of Key Resolutions - Shareholders approved the sale of substantially all of the company's assets, with 97.922% of shareholders in favor, and 97.542% of minority shareholders supporting the resolution [2]. - A name change from "Deveron Corp." to "Finis Holdings Inc." was approved by 97.921% of shareholders present [3]. - The delisting of the company's common shares from the TSX Venture Exchange received approval from 97.922% of shareholders and 97.361% of minority shareholders [4]. - Shareholders approved the application to cease being a reporting issuer, with 97.922% in favor [5]. - A resolution for the voluntary winding up of the company was approved by 97.922% of shareholders and 97.542% of minority shareholders [6]. Group 2: Transaction and Future Outlook - The completion of the asset sale transaction is subject to the satisfaction of all conditions precedent, with an anticipated closing date around January 15, 2026 [7].

Core Insights - Mountain Valley MD Holdings Inc. (MVMD) is focused on disciplined execution across its business lines, aiming for measured growth in product development and commercialization [1] Nutraceuticals - MVMD's Quicksome™ technology optimizes molecule delivery in sublingual nutraceutical applications, enhancing efficacy, precise dosing, and dose sparing [2][3] - The company has an exclusive manufacturing and licensing agreement with a U.S.-based GMP production partner to support Quicksome™ formulations [3] - MVMD is advancing its nutraceutical strategy through partnerships, including a novel testosterone formulation for men, expected to launch in the first half of 2026 [5] Agriculture - MVMD is commercializing its Agrarius™ plant signaling technology, which aims to increase crop yields and reduce fertilizer usage [8] - Trials in Brazil have shown that Agrarius-treated citrus orchards achieved over 50% productivity gains and improved resilience to stress [11][12] - The company is also conducting trials in Colombia, demonstrating improved pasture quality and vegetation health [17] Husbandry Animals and Aquatic Species - MVMD's Soluvec™ 1% formulation, utilizing Quicksol™ technology, aims to provide safer administration of ivermectin for husbandry animals and aquatic species [18] - The company has entered into a licensing agreement in Bangladesh for the production and distribution of Soluvec™ products [19] - Despite initial challenges in commercial traction, MVMD is focusing on royalty-based licensing opportunities for Soluvec™ [21][24]

Core Insights - The article highlights the collaborative efforts between universities and local enterprises in Suifenhe City, aiming to enhance productivity and innovation in various sectors through technology transfer and research partnerships [5][6][7] Group 1: Collaborative Projects - The project on "Amino Nucleoside Industry System Upgrade" led by Professor Xu Meijuan's team in collaboration with Xinghu Biotechnology is expected to increase product efficiency by over 40% [5] - The partnership between Anda Jidi Oilfield Company and Professor Zheng Renzhao's team from Zhejiang University focuses on developing a green oil displacement agent, projected to generate an additional output value of 40 million yuan [5] - The collaboration with Harbin Institute of Technology aims to integrate AI and Beidou navigation into a 20,000-acre unmanned smart farm, improving operational efficiency by over 30% [5] Group 2: Talent and Innovation - In 2025, Suifenhe City plans to introduce 74 university experts to serve in various advisory roles, facilitating 47 industry-university-research collaborations and transitioning 13 technological achievements from research to market [6] - Over the past year, the talent attraction initiative has successfully brought in over 8,000 individuals, marking a historical breakthrough for the city [6] - Five technology small courtyards developed in collaboration with China Agricultural University have been recognized nationally, with the highest new additions in the province [6] Group 3: Future Directions - The city aims to focus on new sectors such as corn bio-economy, digital economy, and cultural tourism by 2026, further deepening the collaboration between academia and local industries [7] - This strategy is expected to generate new productive forces and contribute to the sustainable revitalization of the region [7]

Core Viewpoint - Deveron Corp. is undergoing a proposed transaction that requires additional disclosure as requested by the Ontario Securities Commission, with a special meeting of shareholders scheduled for December 30, 2025, to approve the transaction [1]. Group 1: Transaction Details - The proposed transaction was initially announced on November 3, 2025, and involves a management information circular dated December 1, 2025, which is under review by the Ontario Securities Commission [1]. - The Company received a letter of intent from Aqua Capital on November 14, 2024, for a debenture financing, but did not engage due to negative covenants in a prior settlement agreement [2]. - By February 2025, the Company decided to re-engage with strategic investors, including Aqua Capital, and formed a special committee to explore strategic options [3]. - The Special Committee began negotiations with Aqua Capital in March 2025 regarding a merger and acquisition transaction rather than financing [4]. Group 2: Board Changes and Governance - On April 8, 2025, a board member resigned due to disagreement over the potential transaction with Aqua Capital, but the remaining members approved an updated non-binding letter of intent [5]. - By October 27, 2025, several board members resigned due to concerns about the Company's financial stability, leaving Mr. David MacMillan as the sole director [6]. Group 3: Regulatory and Shareholder Approval - The Ontario Securities Commission views the amendment of the Company's convertible debentures and the proposed transaction as "connected transactions," affecting minority approval requirements [7]. - A total of 20,538,287 common shares, approximately 9.6% of the issued shares, will be excluded from the minority approval calculation for the transaction [7]. - The Company will not proceed with the Wind-Up if a material change occurs that could increase the market price of the common shares before implementation [8]. Group 4: Shareholder Engagement - The Company has waived the proxy cut-off time, allowing shareholders to deposit their executed proxy forms until the start of the meeting on December 30, 2025 [9].

Core Points - Deveron Corp. has announced the resignation of three directors: Roger Dent, Greg Patterson, and Ron Patterson, effective immediately, and expressed gratitude for their contributions [1] - The company has appointed Chris Irwin as a new director, who has extensive experience in securities and corporate law, and has been managing partner at Irwin Lowy LLP since January 2010 [2] Company Overview - Deveron is an agriculture technology company focused on using data and insights to enhance agricultural productivity, reduce costs, and improve farm outcomes through a digital process that interprets production decisions based on data collected across North America [4]

Core Points - Deveron Corp. is unable to file its audited consolidated financial statements for the year ended June 30, 2025, by the deadline of October 28, 2025, due to financial difficulties [1] - The company has not provided an estimate for when it will be able to complete the Annual Filings [1] Company Overview - Deveron is an agriculture technology company that utilizes data and insights to assist farmers and large agricultural enterprises in increasing yields, reducing costs, and improving farm outcomes [2] - The company employs a digital process that leverages data collected on farms across North America to drive unbiased interpretation of production decisions, ultimately recommending how to optimize input use [2]

Core Points - Deveron Corp. has entered into an amending agreement to its forbearance agreement with Toronto Dominion Bank, extending the forbearance period until December 12, 2025, or until a specified termination event occurs [1][2] - The company currently has approximately $25 million in outstanding term debt and drawn on an operating line of credit [1] - The forbearance agreement allows the continuation of the company's strategic review process to evaluate alternatives for meeting short-term liquidity needs [2] Company Overview - Deveron is an agriculture technology company focused on using data and insights to enhance agricultural productivity, reduce costs, and improve farm outcomes [4] - The company employs a digital process that leverages data collected from farms across North America to provide unbiased recommendations for optimizing input use [4]

Core Viewpoint - Corteva plans to separate into two independent, publicly traded companies: New Corteva (Crop Protection) and SpinCo (Seed) to enhance focus and growth opportunities for both segments [2][3][4] Company Overview - Corteva has established itself as a leader in the agriculture technology sector, focusing on innovation and operational excellence [4][6] - The separation aims to create two distinct market leaders, each with tailored capital allocation strategies and growth priorities [3][5] Strategic Rationale - The separation is seen as a logical step to maximize long-term value creation by allowing each business to focus on its own market dynamics and growth strategies [5][7] - New Corteva will emphasize differentiated, innovative solutions, particularly in the biologicals segment, which is the fastest-growing market area [6][8] Financial Projections - Estimated net sales for New Corteva in 2025 are projected to be $7.8 billion, accounting for 44% of Corteva's total net sales [6][10] - SpinCo is expected to generate $9.9 billion in net sales in 2025, representing 56% of Corteva's total net sales [10][17] Transaction Details - The separation is expected to be completed in the second half of 2026 and is intended to qualify as a tax-free transaction for U.S. federal tax purposes [6][10][11] - The transaction is subject to various conditions, including board approval and legal opinions regarding its tax-free nature [11] Leadership and Management - Current Corteva Chair Greg Page will lead New Corteva, while CEO Chuck Magro will head SpinCo, with full management teams to be announced later [3][4]